Fundamentals of HIV Medicine 2023

Editor-in-Chief: Hardy W. David

Language: English

Approximative price 82.73 €

In Print (Delivery period: 21 days).

Add to cartAdd to cart
Publication date:
592 p. · 21.7x28 cm · Paperback
The essential textbook for HIV care providers and pharmacists?updated for 2023! Fundamentals of HIV Medicine has served as a key resource for clinicians preventing and treating HIV for over a decade. An end-to-end clinical resource for the treatment of individuals with HIV/AIDS, Fundamentals of HIV Medicine 2023 offers practitioners immediate, indexed access to the most recent science, research, and guidelines related to all aspects of HIV care and prevention. Now updated to reflect the convergent knowledge at the intersection of two global pandemics, HIV and COVID-19, Fundamentals of HIV Medicine 2023 offers state-of-the-art continuing education for physicians, pharmacists, nurse practitioners, PAs, nurses, and other professionals working in the care of people with HIV. This revised edition features key clinical updates across classic domains of HIV medicine along with new understandings of injectable antiretroviral treatment and explorations into concepts of HIV latency for long-term viral remission. Embodying the American Academy of HIV Medicine's commitment to excellence in the care of seropositive patients, Fundamentals of HIV Medicine 2023 is a must-have for health professionals across HIV care, treatment, and prevention.
About the Editor in Chief: W. David Hardy, MD, is a scientific and medical consultant focusing on developing novel vaccine and cure/remission strategies for human viral diseases. Currently, he serves as Treasurer on the Board of Directors and member of the Executive Committee of the AAHIVM. He has served as Editor in Chief of AAHIVM's comprehensive clinical textbook, Fundamentals of HIV Medicine, since 2007. Dr. Hardy has cared for persons with HIV infection since 1982 and conducted research on HIV and related diseases since 1984. His research focuses on treatment and prevention of opportunistic infections, antiretroviral therapy, immunotherapies, and hepatitis treatments as well as retroviral vector research and cellular and gene therapy for the cure of HIV treatment. Dr. Hardy served as Chair of the Board of Directors of the HIV Medicine Association (HIVMA) and volunteered with several community-based organizations, including AIDS Research Alliance and Project Angel Food. About the American Academy of HIV Medicine (AAHIVM): The American Academy of HIV Medicine is the nation's leading independent organization of health care professionals dedicated to providing excellence in HIV care and prevention. The Academy's membership of practitioners and credentialed clinicians manage the health of the majority of people with and at risk of HIV in the United States.